,NU 636 Quiz 1 Advanced Pharmacology |
Herzing University | 26/27 Actual (PDF)
1. A drug's volume of distribution is primarily determined by which of the following factors?
A) The drug's rate of hepatic metabolism
B) The drug's binding to plasma proteins and tissue components
C) The drug's renal clearance rate
D) The drug's route of administration
Correct Answer: The drug's binding to plasma proteins and tissue components
Rationale: Volume of distribution reflects the extent of drug distribution into body compartments and
is influenced by plasma protein binding and tissue binding. Hepatic metabolism and renal clearance
affect elimination, not distribution. Route of administration influences bioavailability but not the
theoretical volume into which a drug distributes.
2. Which pharmacokinetic parameter represents the fraction of an administered dose that reaches
systemic circulation unchanged?
A) Clearance
B) Half-life
C) Bioavailability
D) Volume of distribution
Correct Answer: Bioavailability
Rationale: Bioavailability is the proportion of a drug that enters systemic circulation in an active form.
Clearance measures the volume of plasma cleared of drug per unit time. Half-life is the time required
for plasma concentration to decrease by 50%. Volume of distribution relates dose to plasma
concentration.
,3. A drug that binds to a receptor and produces a maximal response while preventing other ligands
from binding is best classified as which of the following?
A) Partial agonist
B) Competitive antagonist
C) Full agonist
D) Irreversible antagonist
Correct Answer: Full agonist
Rationale: A full agonist binds to a receptor and produces a maximal biologic response. A partial
agonist produces a submaximal response even at full receptor occupancy. A competitive antagonist
prevents agonist binding but produces no response. An irreversible antagonist permanently
inactivates receptors.
4. The therapeutic index of a drug is calculated by which of the following ratios?
A) Median effective dose divided by median lethal dose
B) Median lethal dose divided by median effective dose
C) Peak plasma concentration divided by trough plasma concentration
D) Volume of distribution divided by clearance
Correct Answer: Median lethal dose divided by median effective dose
Rationale: The therapeutic index is the ratio of the median lethal dose (LD50) to the median effective
dose (ED50), indicating relative safety. A higher ratio suggests a wider margin of safety. The other
ratios do not represent the therapeutic index.
5. Which statement accurately distinguishes pharmacokinetics from pharmacodynamics?
A) Pharmacokinetics studies drug absorption while pharmacodynamics studies drug distribution
B) Pharmacokinetics examines what the body does to a drug while pharmacodynamics examines what
a drug does to the body
C) Pharmacokinetics evaluates drug toxicity while pharmacodynamics evaluates drug efficacy
, D) Pharmacokinetics analyzes receptor binding while pharmacodynamics analyzes drug metabolism
Correct Answer: Pharmacokinetics examines what the body does to a drug while pharmacodynamics
examines what a drug does to the body
Rationale: Pharmacokinetics encompasses absorption, distribution, metabolism, and excretion—the
body's handling of a drug. Pharmacodynamics describes the biochemical and physiologic effects of
drugs and their mechanisms of action at receptors. The other options misattribute specific processes
to the wrong discipline.
6. A drug that undergoes extensive first-pass metabolism will most likely exhibit which of the
following characteristics when administered orally?
A) Increased bioavailability compared to intravenous administration
B) Reduced systemic concentration compared to intravenous administration
C) Prolonged half-life compared to intravenous administration
D) Enhanced renal elimination compared to intravenous administration
Correct Answer: Reduced systemic concentration compared to intravenous administration
Rationale: First-pass metabolism occurs in the liver and gut wall before a drug reaches systemic
circulation, reducing the orally administered dose's bioavailability. Intravenous administration
bypasses first-pass metabolism, resulting in higher systemic concentrations. First-pass metabolism
does not enhance renal elimination or prolong half-life.
7. Which cytochrome P450 enzyme is responsible for the metabolism of the largest proportion of
clinically used drugs?
A) CYP1A2
B) CYP2D6
C) CYP3A4
D) CYP2C9
Correct Answer: CYP3A4
Herzing University | 26/27 Actual (PDF)
1. A drug's volume of distribution is primarily determined by which of the following factors?
A) The drug's rate of hepatic metabolism
B) The drug's binding to plasma proteins and tissue components
C) The drug's renal clearance rate
D) The drug's route of administration
Correct Answer: The drug's binding to plasma proteins and tissue components
Rationale: Volume of distribution reflects the extent of drug distribution into body compartments and
is influenced by plasma protein binding and tissue binding. Hepatic metabolism and renal clearance
affect elimination, not distribution. Route of administration influences bioavailability but not the
theoretical volume into which a drug distributes.
2. Which pharmacokinetic parameter represents the fraction of an administered dose that reaches
systemic circulation unchanged?
A) Clearance
B) Half-life
C) Bioavailability
D) Volume of distribution
Correct Answer: Bioavailability
Rationale: Bioavailability is the proportion of a drug that enters systemic circulation in an active form.
Clearance measures the volume of plasma cleared of drug per unit time. Half-life is the time required
for plasma concentration to decrease by 50%. Volume of distribution relates dose to plasma
concentration.
,3. A drug that binds to a receptor and produces a maximal response while preventing other ligands
from binding is best classified as which of the following?
A) Partial agonist
B) Competitive antagonist
C) Full agonist
D) Irreversible antagonist
Correct Answer: Full agonist
Rationale: A full agonist binds to a receptor and produces a maximal biologic response. A partial
agonist produces a submaximal response even at full receptor occupancy. A competitive antagonist
prevents agonist binding but produces no response. An irreversible antagonist permanently
inactivates receptors.
4. The therapeutic index of a drug is calculated by which of the following ratios?
A) Median effective dose divided by median lethal dose
B) Median lethal dose divided by median effective dose
C) Peak plasma concentration divided by trough plasma concentration
D) Volume of distribution divided by clearance
Correct Answer: Median lethal dose divided by median effective dose
Rationale: The therapeutic index is the ratio of the median lethal dose (LD50) to the median effective
dose (ED50), indicating relative safety. A higher ratio suggests a wider margin of safety. The other
ratios do not represent the therapeutic index.
5. Which statement accurately distinguishes pharmacokinetics from pharmacodynamics?
A) Pharmacokinetics studies drug absorption while pharmacodynamics studies drug distribution
B) Pharmacokinetics examines what the body does to a drug while pharmacodynamics examines what
a drug does to the body
C) Pharmacokinetics evaluates drug toxicity while pharmacodynamics evaluates drug efficacy
, D) Pharmacokinetics analyzes receptor binding while pharmacodynamics analyzes drug metabolism
Correct Answer: Pharmacokinetics examines what the body does to a drug while pharmacodynamics
examines what a drug does to the body
Rationale: Pharmacokinetics encompasses absorption, distribution, metabolism, and excretion—the
body's handling of a drug. Pharmacodynamics describes the biochemical and physiologic effects of
drugs and their mechanisms of action at receptors. The other options misattribute specific processes
to the wrong discipline.
6. A drug that undergoes extensive first-pass metabolism will most likely exhibit which of the
following characteristics when administered orally?
A) Increased bioavailability compared to intravenous administration
B) Reduced systemic concentration compared to intravenous administration
C) Prolonged half-life compared to intravenous administration
D) Enhanced renal elimination compared to intravenous administration
Correct Answer: Reduced systemic concentration compared to intravenous administration
Rationale: First-pass metabolism occurs in the liver and gut wall before a drug reaches systemic
circulation, reducing the orally administered dose's bioavailability. Intravenous administration
bypasses first-pass metabolism, resulting in higher systemic concentrations. First-pass metabolism
does not enhance renal elimination or prolong half-life.
7. Which cytochrome P450 enzyme is responsible for the metabolism of the largest proportion of
clinically used drugs?
A) CYP1A2
B) CYP2D6
C) CYP3A4
D) CYP2C9
Correct Answer: CYP3A4
